Lv5
960 积分 2020-09-28 加入
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2小时前
待确认
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
2小时前
待确认
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2小时前
待确认
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2小时前
已完结
Global, regional and national burden of alopecia areata and its associated diseases, 1990–2019: A systematic analysis of the Global Burden of Disease Study 2019
19天前
已完结
布瑞哌唑片治疗成人急性期精神分裂症患者的临床研究
2个月前
已完结
Temporal arteritis in Hong Kong
2个月前
已完结
药物临床试验中不良事件的案例收集与评判
3个月前
已完结
EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
4个月前
已完结
皖公网安备34019202002308
